Moss, 20 April 2026
Gentian Diagnostics, a fast-growing developer and manufacturer of high-quality
diagnostic assays, is pleased to announce the renewal of its long-term supply
agreement with Bühlmann Laboratories for faecal calprotectin. Under the renewed
agreement, Gentian will continue to supply key materials for Bühlmann
Laboratories market-leading faecal calprotectin assay, fCAL Turbo®.
The renewal underscores the strength of the long standing collaboration between
Gentian and Bühlmann Laboratories and reflects a shared commitment to advancing
faecal calprotectin testing to support improved diagnosis and monitoring of
inflammatory bowel disease.
Matti Heinonen, CEO of Gentian Diagnostics ASA, commented: "We are very pleased
to extend our partnership with Bühlmann Laboratories. Bühlmann has proven to be
a strong partner with a continued commitment to developing the faecal
calprotectin market. This agreement provides a solid foundation for long term
value creation for both companies."
Christian Eberle, CEO of Bühlmann Laboratories AG, stated: "This new agreement
with our long standing partner Gentian ensures continuity and provides a strong
foundation for our collaboration going forward."
For further information, please contact:
Njaal Kind, CFO
njaal.kind@gentian.no
+47 919 06 525
About Gentian Diagnostics
Gentian Diagnostics (OSE: GENT) develops and manufactures high-quality in vitro
diagnostic reagents. Our mission is to improve diagnostic efficiency to support
better treatment decisions. Gentian's expertise and focus lie in immunoassays,
specifically within infections, inflammation, kidney disease, and heart failure.
By converting existing, clinically relevant biomarkers to the most efficient
high throughput analysers, the company contributes to cost savings and helps
protect lives. Gentian Diagnostics is headquartered in Moss, Norway, and serves
the global human and veterinary diagnostics markets through sales and
representative offices in Sweden, the USA, and China. For more information,
please visit www.gentian.com.